Evidence map›Paper›PMID 24919190›Full record

ArticlePloS one2014

Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer disease.

Aurélie Hendrickx, Nathalie Pierrot, Bernadette Tasiaux, Olivier Schakman, Pascal Kienlen-Campard, Charles De Smet, Jean-Noël Octave

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Neuroprotective effects of G9a inhibition and cannabinoid receptor activation in Alzheimer's disease through a pharmacological approach.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aurélie HendrickxAlzheimer Dementia, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
Nathalie PierrotAlzheimer Dementia, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
Bernadette TasiauxAlzheimer Dementia, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
Olivier SchakmanCell Physiology, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
Pascal Kienlen-CampardAlzheimer Dementia, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
Charles De SmetGenetic & Epigenetic Alterations in Genomes, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Jean-Noël OctaveAlzheimer Dementia, Institute of Neurosciences (IoNS), Université catholique de Louvain, Brussels, Belgium.
UCLouvain · BEde Duve Institute · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously demonstrated that APP epigenetically regulates Egr1 expression both in cultured neurons and in vivo. Since Egr1 is an immediate early gene involved in memory formation, we wondered whether other early genes involved in memory were regulated by APP and we studied molecular mechanisms involved. By comparing prefrontal (PF) cortex from wild type (APP+/+) and APP knockout mice (APP-/-), we observed that APP down regulates expression of four immediate early genes, Egr1, c-Fos, Bdnf and Arc. Down regulation of Egr1, c-Fos and Bdnf transcription resulted from a decreased enrichment of acetylated histone H4 on the corresponding gene promoter. Further characterization of H4 acetylation at Egr1 and c-Fos promoters revealed increased acetylation of H4K5 and H4K12 residues in APP-/- mice. Whereas APP affected Egr1 promoter activity by reducing access of the CREB transcription factor, its effect on c-Fos appeared to depend on increased recruitment of HDAC2 histone deacetylase to the gene promoter. The physiological relevance of the epigenetic regulation of Egr1 and c-Fos gene transcription by APP was further analyzed following exposure of mice to novelty. Although transcription of Egr1 and c-Fos was increased following exposure of APP+/+ mice to novelty, such an induction was not possible in APP-/- mice with a high basal level of expression of these immediate early genes. Altogether, these results demonstrate that APP-mediated regulation of c-Fos and Egr1 by different epigenetic mechanisms is needed for their induction during exposure to novelty.

Indexed as

Epigenesis, GeneticGene Expression RegulationGenes, Immediate-EarlyMemoryAcetylationAmyloid beta-Protein PrecursorBase SequenceChromatin ImmunoprecipitationDNA PrimersEarly Growth Response Protein 1HistonesHumansReal-Time Polymerase Chain ReactionAmyloid beta-Protein PrecursorDNA PrimersEarly Growth Response Protein 1EGR1 protein, humanHistones

Identifiers

PMID24919190
PMCPMC4053420
OpenAlexW2079936759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.